| Autor: |
Stege G; Department of Pulmonology, Rijnstate Hospital, PO Box 9555, 6800 TA, Arnhem, The Netherlands. gstege@alysis.nl , Vos PJ, van den Elshout FJ, Richard Dekhuijzen PN, van de Ven MJ, Heijdra YF |
| Jazyk: |
angličtina |
| Zdroj: |
Respiratory medicine [Respir Med] 2008 Jun; Vol. 102 (6), pp. 801-14. Date of Electronic Publication: 2008 Mar 07. |
| DOI: |
10.1016/j.rmed.2007.12.026 |
| Abstrakt: |
The quality of sleep is significantly compromised in many patients with chronic obstructive pulmonary disease (COPD) and may be further diminished when certain comorbidities are present. A reduced sleep quality is associated with daytime consequences like fatigue, psychiatric problems and an impaired quality of life. Sleep induces physiologic alterations in respiratory function, which can become pathologic and may provoke or worsen hypoxemia and hypercapnia in COPD. Dyspnea, cough and excessive mucus production should be optimised to minimise causes for sleep disturbance. Pharmacological therapy may be helpful; sedatives like benzodiazepines and non-benzodiazepine benzodiazepine-receptor agonists (NBBRAs) are (equally) effective in improving sleep quality. Whether or not these hypnotics produce serious adverse respiratory effects during sleep, remains unclear due to opposing studies. Therefore, their use should be as short as possible. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect